| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/10/2004 | US6773716 Over-coated chewing gum formulations |
| 08/10/2004 | US6773708 Suppression of excessive th1 and stimulation of th2 cell mediated immune responses |
| 08/10/2004 | US6773701 Expression enhancer for protein synthesis inhibitory genes |
| 08/10/2004 | CA2457651A1 Antibodies for discrimination of prions |
| 08/10/2004 | CA2163253C N-p-halobenzoylmethyl derivatives of 4-(p-fluorophenyl)-3-¬¬3,4-methylenedioxy)phenoxy|methyl|piperidine |
| 08/10/2004 | CA2149013C A novel arylpropionic derivative, a process for the preparation and the use thereof as an analgesic agent |
| 08/10/2004 | CA2147759C Tilidin dihydrogen orthophosphate, method of preparing it and pharmaceutical preparations containing it |
| 08/10/2004 | CA2134566C 1-piperazino-1,2-dihydroindene derivatives |
| 08/06/2004 | CA2454337A1 Pharmaceutical compositions for the treatment of movement disorders |
| 08/05/2004 | WO2004065960A1 Novel screening method |
| 08/05/2004 | WO2004065599A1 Lrp4/CORIN DOPAMINE-PRODUCING NEURON PROLIFERATION PRECURSOR CELL MARKER |
| 08/05/2004 | WO2004065572A2 Proteic binding partners of tctp and methods of modulating tumor reversion or cell apoptosis |
| 08/05/2004 | WO2004065388A1 Fluoroimidazopyrimidines as gaba-a alpha 2/3 ligands for depression/anxiety |
| 08/05/2004 | WO2004065385A1 Novel nitrogen-containing cyclic compounds |
| 08/05/2004 | WO2004065381A1 Process for making ondansetron and intermediates thereof |
| 08/05/2004 | WO2004065349A1 Medically useful 1-phenyl-2-aminomethyl naphthalenes, method for producing them, drugs containing them and use thereof |
| 08/05/2004 | WO2004065348A1 Pharmaceutically acceptable salts of sertraline and pharmaceutical compositions thereof |
| 08/05/2004 | WO2004064912A1 An otorhinological delivery device |
| 08/05/2004 | WO2004064869A2 Amyloid-binding, metal-chelating agents |
| 08/05/2004 | WO2004064861A1 Nerve cell death inhibitor |
| 08/05/2004 | WO2004064839A1 Salts of codrugs of an opioid together with a second active moiety and uses thereto |
| 08/05/2004 | WO2004064832A2 Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist |
| 08/05/2004 | WO2004064831A1 Compounds having anti-proliferative properties |
| 08/05/2004 | WO2004064827A1 Use of porphyrin synthesis substances for carrying out phototherapy and for curing skin and articulation diseases |
| 08/05/2004 | WO2004064811A1 A composition material for transmucosal delivery |
| 08/05/2004 | WO2004064764A2 Substituted alkyl amido piperidines |
| 08/05/2004 | WO2004064753A2 Use of n-desmethylclozapine to treat human neuropsychiatric disease |
| 08/05/2004 | WO2004064738A2 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 08/05/2004 | WO2004064721A2 A pyrazolopyrimidine compound and a process for preparing the same |
| 08/05/2004 | WO2004064713A2 The use of yop preoteins or rho gtpase inhibitors as caspase-1 inhibitors |
| 08/05/2004 | WO2004037234A3 Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors |
| 08/05/2004 | WO2004029192A3 Producing method of tien hsien liquid |
| 08/05/2004 | WO2004022716A9 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 08/05/2004 | WO2004010974A3 Gelatin capsule exhibiting reduced cross-linking |
| 08/05/2004 | WO2004010973A3 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 08/05/2004 | WO2003086288A3 Bicyclic amides |
| 08/05/2004 | WO2003051303A3 The total synthesis of merrilactone a |
| 08/05/2004 | WO2003042359A3 Histamine receptor h3 polynucleotides |
| 08/05/2004 | WO2003029411A3 Novel cyclooxygenase variants and methods of use |
| 08/05/2004 | WO2003015768A3 Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades |
| 08/05/2004 | US20040153126 Method and apparatus for treating uterine myoma |
| 08/05/2004 | US20040152906 Sulfonamides |
| 08/05/2004 | US20040152902 N-substituted aniline and diphenylamine analogs |
| 08/05/2004 | US20040152893 Sulfonamides |
| 08/05/2004 | US20040152891 Sulfonamides |
| 08/05/2004 | US20040152888 novel benzodiazepine derivatives |
| 08/05/2004 | US20040152789 Complex of calcium compound and phosphate; adjustment pH |
| 08/05/2004 | US20040152781 Use of acetyl l-carnitine for the prepartion of a medication for the preventive therapy for pain |
| 08/05/2004 | US20040152779 Bicyclic amino acids as pharmaceutical agents |
| 08/05/2004 | US20040152775 Using a compound containing a amine and a sulfinate group; gastrointestinal disorders |
| 08/05/2004 | US20040152761 Dimeric isoflavones |
| 08/05/2004 | US20040152760 Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases |
| 08/05/2004 | US20040152754 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/05/2004 | US20040152753 Methods of use for novel sulfur containing organic nitrate compounds |
| 08/05/2004 | US20040152751 Viricides; suppress lymphocytes; aids therapy; antiinflammatory agents |
| 08/05/2004 | US20040152747 Central nervous system disorders; Alzheimer's disease; strokes; Down's syndrome; cognition activators; anxiolytic agents; antidepressants; sleep disorders; antiinflammatory agents |
| 08/05/2004 | US20040152744 Phenylacetic acid derivative; hypoglycemic agents; antilipemic agents; antichoilesterol agents; cardiovascular disorders |
| 08/05/2004 | US20040152741 Arylglycine derivatives and their use as glycine transport inhibitors |
| 08/05/2004 | US20040152738 Wound healing agents; antiarthritic agents; osteoporosis; congestive heart failure; antiulcer agents; Alzheimer's disease; anticholesterol agents; antiarthritic agents |
| 08/05/2004 | US20040152737 Attention deficit hypoactivity disorders |
| 08/05/2004 | US20040152735 NO-synthase inhibitors comprising N,N'-bis(2-pyridyl)methyl-N,N'-bis(3,4,5-trimethoxybenzyl) ethylenediamine |
| 08/05/2004 | US20040152734 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds |
| 08/05/2004 | US20040152731 4-(Phenyl-(piperidin-4-yl)-amino)-benzamide derivaties and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 08/05/2004 | US20040152730 Novel compounds |
| 08/05/2004 | US20040152726 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 08/05/2004 | US20040152725 Anticancer agents using a compound containing urea group |
| 08/05/2004 | US20040152723 Pharmaceutical compositions and methods for use |
| 08/05/2004 | US20040152722 Use of phencynonate hydrochloride |
| 08/05/2004 | US20040152715 Controlling activation of n-methylaspartic acid sensitive diseases; central nervous system disorders; Alzheimer's and Parkinson's disease |
| 08/05/2004 | US20040152713 Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist |
| 08/05/2004 | US20040152706 Antidepressants; Alzheimer's disease; Parkinson's disease; anxiolytic agents; analgesics; strokes; brain disorders; hypotensive agents; obesity; antihistamines; immunosuppressants; antiulcer agents |
| 08/05/2004 | US20040152702 Benzoxazol derivatives |
| 08/05/2004 | US20040152700 Novel use of 2-phenyl-substituted imidazotriazinones |
| 08/05/2004 | US20040152699 Compounds |
| 08/05/2004 | US20040152692 Pyrrolidine sulfonamides |
| 08/05/2004 | US20040152689 Therapeutic agents useful for treating pain |
| 08/05/2004 | US20040152681 Interact with nuclear liver X receptor (LXR) and ubiquitous receptor (UR) and can be used to treat a variety of LXR- or UR-mediated disorders |
| 08/05/2004 | US20040152680 Treating autoimmune diseases, skin disorders, malignancies |
| 08/05/2004 | US20040152679 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152678 Administering 20S)-1 alpha -hydroxy-2 alpha -methyl-19-nor-vitamin D3 for therapy of psoriasis |
| 08/05/2004 | US20040152677 (20S)-1alpha-hydroxy-2alpha-methl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152676 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152675 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152658 For therapy of animal having a deficiency in a neuron's immediate early gene responsiveness to a stimulus |
| 08/05/2004 | US20040152653 Administering a pharmacologic complex to the airway epithelium via its luminal surface, wherein the complex comprises a ligand for serpin enzyme complex receptor (SecR) and a pharmacologic agent |
| 08/05/2004 | US20040152163 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems |
| 08/05/2004 | US20040152161 Comprises type I membrane protein receptor for identifying modulators for treatment of cell proliferation, leukopenia, anemia, thrombocytopenia, osteoporosis and neurodegenerative disorders |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040152138 Using dementia related osteoponton (DROPN) peptides to diagnose, prognose and identify treatments for progressive neurodegenerative diseases |
| 08/05/2004 | US20040152111 Compositions and methods for diagnosing and treating mood disorders |
| 08/05/2004 | US20040152101 for diagnostic/therapeutic/prophylactics for neurodegenerative diseases, brain dysfunctions, cancers, gastrointestinal/circulatory/endocrine diseases and cell death; genetic engineering |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | US20040151740 treating strabismus by administering of a neurotoxic component of a botulinum toxin free of a botulinum toxin complex protein. |
| 08/05/2004 | US20040151739 transporter and fusion protein contains a binding domain for the transporter and a modulation domain for the covalent modification of small GTP-binding proteins; transporter permits the uptake of the fusion protein in a target cell |
| 08/05/2004 | US20040151701 culturing the mesenchymal stem cells in a medium containing epidermal growth factor, basic fibroblast growth factor and hepatocyte growth factor; treating Parkinson's, Alzheimer's, Pick's, Huntington's, and brain ischemic diseases and ALS |
| 08/05/2004 | DE20220910U1 Zusammensetzungen zur Verhinderung des Missbrauchs von Opioiden Compositions to prevent the misuse of opioids |
| 08/05/2004 | DE10252666A1 N-Piperidyl-cyclohexan-Derivate N-piperidyl-cyclohexane derivatives |
| 08/05/2004 | CA2514325A1 A composition material for transmucosal delivery |
| 08/05/2004 | CA2514200A1 Amyloid-binding, metal-chelating agents |
| 08/05/2004 | CA2513584A1 The use of yop proteins or rho gtpase inhibitors as caspase-1 inhibitors |